Sheridan, WY – CoreAgeRx, a tele‑medicine company headquartered in Sheridan, announced the rollout of three preventive longevity protocols designed to support metabolic health and age‑related wellness. The programs use low, consistent doses of semaglutide, tirzepatide and sermorelin, which the company markets as a more sustainable alternative to traditional high‑dose weight‑loss treatments.

Micro‑dosing Semaglutide

Priced at $149 per month, the semaglutide protocol targets insulin sensitivity, stable glucose control and lean body composition. The company says the low‑dose approach reduces side‑effects while promoting steady energy levels and long‑term physiological function.

Micro‑dosing Tirzepatide

At $199 per month, the tirzepatide protocol combines GLP‑1 and GIP receptor activity to enhance metabolic flexibility, nutrient utilization and cardiometabolic health. CoreAgeRx emphasizes that the dual‑pathway effect aims to improve body‑composition quality and lower systemic inflammation with fewer side‑effects than higher‑dose regimens.

Sermorelin Therapy

For $99 per month, the sermorelin program stimulates the body’s own growth hormone release by acting on the pituitary gland. The company highlights benefits such as improved fat metabolism, muscle tone, skin elasticity, deeper sleep and faster recovery from exercise or injury.

All three protocols are delivered through CoreAgeRx’s 100% online platform. Patients receive care from U.S. board‑certified physicians, medications compounded by U.S. pharmacies, and free, fast delivery to their doors, without long‑term contracts.

CoreAgeRx describes the offerings as part of a broader effort to shift health and wellness from reactive treatment to proactive health‑span optimization. Interested individuals can learn more or begin a confidential consultation at coreagerx.com.

Original reporting: KTBS 3 (Shreveport) — read the source article.